This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Sep;74(3):322-323.

doi: 10.1016/j.eururo.2018.05.001. Epub 2018 May 23.

Choosing Front-line Treatment for Metastatic Renal Cancer: Which Data Are Meaningful?

Tom Powles¹

Affiliations

PMID: 29801664
DOI: 10.1016/j.eururo.2018.05.001

Editorial

Choosing Front-line Treatment for Metastatic Renal Cancer: Which Data Are Meaningful?

Tom Powles. Eur Urol. 2018 Sep.

. 2018 Sep;74(3):322-323.

doi: 10.1016/j.eururo.2018.05.001. Epub 2018 May 23.

Author

Tom Powles¹

Affiliation

¹ Barts Cancer Centre, Royal Free and St. Bartholomew's Hospitals, Queen Mary's University, London, UK. Electronic address: thomas.powles@bartshealth.nhs.uk.

PMID: 29801664
DOI: 10.1016/j.eururo.2018.05.001

No abstract available

PubMed Disclaimer

Comment on

First-line Systemic Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.
Wallis CJD, Klaassen Z, Bhindi B, Ye XY, Chandrasekar T, Farrell AM, Goldberg H, Boorjian SA, Leibovich B, Kulkarni GS, Shah PS, Bjarnason GA, Heng DYC, Satkunasivam R, Finelli A. Wallis CJD, et al. Eur Urol. 2018 Sep;74(3):309-321. doi: 10.1016/j.eururo.2018.03.036. Epub 2018 Apr 13. Eur Urol. 2018. PMID: 29656851

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations